Integrating Global and National Knowledge to Select Medicines for Children: The Ghana National Drugs Programme
Open Access
- 21 May 2013
- journal article
- health in-action
- Published by Public Library of Science (PLoS) in PLOS Medicine
- Vol. 10 (5) , e1001449
Abstract
David Sinclair and colleagues discuss their experience at the Ghana National Drugs Programme reviewing the international evidence base for five priority pediatric medicines and report that applying the global recommendations to Ghana was not straightforward for any of the five medicines. Please see later in the article for the Editors' SummaryKeywords
This publication has 15 references indexed in Scilit:
- Oral zinc for treating diarrhoea in children2012
- The effect of Ghana's National Health Insurance Scheme on health care utilisation.2012
- Cost-effectiveness of parenteral artesunate for treating children with severe malaria in sub-Saharan AfricaBulletin of the World Health Organization, 2011
- Artesunate versus quinine in the treatment of severe falciparum malaria in African children (AQUAMAT): an open-label, randomised trialThe Lancet, 2010
- SUPPORT Tools for evidence-informed Policymaking in health 11: Finding and using evidence about local conditionsHealth Research Policy and Systems, 2009
- SUPPORT Tools for evidence-informed health Policymaking (STP)Health Research Policy and Systems, 2009
- Recommendations for treatment of childhood non-severe pneumoniaThe Lancet Infectious Diseases, 2009
- Cost‐effectiveness of artesunate for the treatment of severe malariaTropical Medicine & International Health, 2009
- Topical applications of chlorhexidine to the umbilical cord for prevention of omphalitis and neonatal mortality in southern Nepal: a community-based, cluster-randomised trialThe Lancet, 2006
- Criteria list for assessment of methodological quality of economic evaluations: Consensus on Health Economic CriteriaInternational Journal of Technology Assessment in Health Care, 2005